OPPI

The Organisation of Pharmaceutical Producers of India (OPPI) has announced a strategic collaboration with the National Institute…

Industry stakeholders view the Union Budget 2026 as a pivotal inflection point in India’s life sciences journey. With the launch…

As we move closer to 2026, the pharmaceutical ecosystem is undergoing a profound transformation driven by digital innovation,…

Anil Matai, Director General, OPPI: "As India approaches the upcoming Union Budget, OPPI believes that there is an opportunity…

“India is well-positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five…

The EY Parthenon and Organisation of Pharmaceutical Producers of India (OPPI) has unveiled their latest report titled "Fueling…

The Department of Pharmaceuticals (DoP) has announced key amendments to the Uniform Code for Pharmaceutical Marketing Practices…

Regulatory Watch: Anil Matai, Director General of OPPI

Anil Matai, Director General, OPPI observes that while some gaps remain, OPPI is committed to facilitating and partnering with the…

Union Budget 2025-2026 must prioritise innovation, ease of doing business, and policies that strengthen the life sciences…